Statement of deviation or variation for Q4 2025-26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Samsrita Labs Limited has filed a compliance statement confirming there is no deviation or variation in the use of proceeds from a preferential issue that raised Rs. 339.10 lakhs on 18 July 2025. The funds were allocated across four stated purposes: working capital (Rs. 52.10L), investment into new projects/ventures (Rs. 132.46L), repayment of unsecured loans to promoter director (Rs. 88.31L), and general corporate purpose (Rs. 66.23L). The Audit Committee reviewed and approved the statement on 29 May 2026. Notably, under new projects/opportunities, only Rs. 2.00 lakhs was utilized against the allocated Rs. 132.46 lakhs, yet the company has declared no deviation.
The large unutilized portion (Rs. 130.46L) under new projects, with no stated deviation, warrants attention — it may indicate slow deployment or reallocation of funds outside disclosed objects, which shareholders should monitor closely.